Literature DB >> 23746978

Cardiac stem cell therapy and the promise of heart regeneration.

Jessica C Garbern1, Richard T Lee.   

Abstract

Stem cell therapy for cardiac disease is an exciting but highly controversial research area. Strategies such as cell transplantation and reprogramming have demonstrated both intriguing and sobering results. Yet as clinical trials proceed, our incomplete understanding of stem cell behavior is made evident by numerous unresolved matters, such as the mechanisms of cardiomyocyte turnover or the optimal therapeutic strategies to achieve clinical efficacy. In this Perspective, we consider how cardiac stem cell biology has led us into clinical trials, and we suggest that achieving true cardiac regeneration in patients may ultimately require resolution of critical controversies in experimental cardiac regeneration.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23746978      PMCID: PMC3756309          DOI: 10.1016/j.stem.2013.05.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  86 in total

Review 1.  Myocardial regeneration: Roles of stem cells and hydrogels.

Authors:  Zhaoyang Ye; Yan Zhou; Haibo Cai; Wensong Tan
Journal:  Adv Drug Deliv Rev       Date:  2011-03-01       Impact factor: 15.470

2.  Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.

Authors:  Tao-Sheng Li; Ke Cheng; Konstantinos Malliaras; Rachel Ruckdeschel Smith; Yiqiang Zhang; Baiming Sun; Noriko Matsushita; Agnieszka Blusztajn; John Terrovitis; Hideo Kusuoka; Linda Marbán; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

3.  Transient regenerative potential of the neonatal mouse heart.

Authors:  Enzo R Porrello; Ahmed I Mahmoud; Emma Simpson; Joseph A Hill; James A Richardson; Eric N Olson; Hesham A Sadek
Journal:  Science       Date:  2011-02-25       Impact factor: 47.728

Review 4.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

Authors:  Adam R Williams; Joshua M Hare
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

5.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

Authors:  Roberto Bolli; Atul R Chugh; Domenico D'Amario; John H Loughran; Marcus F Stoddard; Sohail Ikram; Garth M Beache; Stephen G Wagner; Annarosa Leri; Toru Hosoda; Fumihiro Sanada; Julius B Elmore; Polina Goichberg; Donato Cappetta; Naresh K Solankhi; Ibrahim Fahsah; D Gregg Rokosh; Mark S Slaughter; Jan Kajstura; Piero Anversa
Journal:  Lancet       Date:  2011-11-14       Impact factor: 79.321

6.  Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes.

Authors:  Bin Zhou; Leah B Honor; Qing Ma; Jin-Hee Oh; Ruei-Zeng Lin; Juan M Melero-Martin; Alexander von Gise; Pingzhu Zhou; Tianyuan Hu; Lingjuan He; Kai Hong Wu; Hui Zhang; Yuebo Zhang; William T Pu
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

Review 7.  Stem cell treatment for acute myocardial infarction.

Authors:  David M Clifford; Sheila A Fisher; Susan J Brunskill; Carolyn Doree; Anthony Mathur; Suzanne Watt; Enca Martin-Rendon
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

8.  Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Joseph Gannon; Richard T Lee
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

9.  De novo cardiomyocytes from within the activated adult heart after injury.

Authors:  Nicola Smart; Sveva Bollini; Karina N Dubé; Joaquim M Vieira; Bin Zhou; Sean Davidson; Derek Yellon; Johannes Riegler; Anthony N Price; Mark F Lythgoe; William T Pu; Paul R Riley
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 10.  Cell therapy for cardiovascular disease: a comparison of methods of delivery.

Authors:  Nabil Dib; Harris Khawaja; Samantha Varner; Megan McCarthy; Ann Campbell
Journal:  J Cardiovasc Transl Res       Date:  2010-12-23       Impact factor: 4.132

View more
  138 in total

1.  Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Stuart Walsh; Sangita Choudhury; Niyatie Ammanamanchi; David G Bennett; Cristobal G dos Remedios; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 2.  Injectable Hydrogels for Cardiac Tissue Engineering.

Authors:  Brisa Peña; Melissa Laughter; Susan Jett; Teisha J Rowland; Matthew R G Taylor; Luisa Mestroni; Daewon Park
Journal:  Macromol Biosci       Date:  2018-05-07       Impact factor: 4.979

3.  Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.

Authors:  Lior Zangi; Kathy O Lui; Alexander von Gise; Qing Ma; Wataru Ebina; Leon M Ptaszek; Daniela Später; Huansheng Xu; Mohammadsharif Tabebordbar; Rostic Gorbatov; Brena Sena; Matthias Nahrendorf; David M Briscoe; Ronald A Li; Amy J Wagers; Derrick J Rossi; William T Pu; Kenneth R Chien
Journal:  Nat Biotechnol       Date:  2013-09-08       Impact factor: 54.908

4.  Hypoxia Prevents Mitochondrial Dysfunction and Senescence in Human c-Kit+ Cardiac Progenitor Cells.

Authors:  Kelli I Korski; Dieter A Kubli; Bingyan J Wang; Farid G Khalafalla; Megan M Monsanto; Fareheh Firouzi; Oscar H Echeagaray; Taeyong Kim; Robert M Adamson; Walter P Dembitsky; Åsa B Gustafsson; Mark A Sussman
Journal:  Stem Cells       Date:  2019-01-30       Impact factor: 6.277

5.  ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.

Authors:  Gabriele D'Uva; Alla Aharonov; Mattia Lauriola; David Kain; Yfat Yahalom-Ronen; Silvia Carvalho; Karen Weisinger; Elad Bassat; Dana Rajchman; Oren Yifa; Marina Lysenko; Tal Konfino; Julius Hegesh; Ori Brenner; Michal Neeman; Yosef Yarden; Jonathan Leor; Rachel Sarig; Richard P Harvey; Eldad Tzahor
Journal:  Nat Cell Biol       Date:  2015-04-06       Impact factor: 28.824

Review 6.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

7.  Derivation of cardiac progenitor cells from embryonic stem cells.

Authors:  Ieng Lam Lei; Lei Bu; Zhong Wang
Journal:  J Vis Exp       Date:  2015-01-12       Impact factor: 1.355

Review 8.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

9.  Image-guided stem cells with functionalized self-assembling peptide nanofibers for treatment of acute myocardial infarction in a mouse model.

Authors:  Xiao Li; Ying-Ying Chen; Xiu-Mei Wang; Kai Gao; Yun-Zhou Gao; Jian Cao; Zhuo-Li Zhang; Jing Lei; Zheng-Yu Jin; Yi-Ning Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

10.  Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue Engineering and Therapy.

Authors:  Anwarul Hasan; Renae Waters; Boustany Roula; Rahbani Dana; Seif Yara; Toubia Alexandre; Arghya Paul
Journal:  Macromol Biosci       Date:  2016-03-08       Impact factor: 4.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.